New test for airway inflammation after allergen challenge in mild asthma
Part of Lungs & breathing clinical trials.
This study tests a new, non-invasive way to measure airway inflammation after breathing in an allergen (like pollen or dust mite). It is for people with mild asthma that is well controlled with only a rescue inhaler.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 65 years old.
- You have mild asthma that is well controlled using only a rescue inhaler (no daily controller meds).
- You are a non-smoker (or quit more than a year ago and smoked less than a pack a day for a year).
- You have a known allergy to common triggers like pollen or dust mites, confirmed by a skin test.
- You have not taken steroids (pills or inhalers) for asthma in the last 4 weeks.
- You have not had a respiratory infection or asthma flare-up in the last month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study looks at how the immune system drives allergic airway inflammation in people with allergic asthma, and compares them with allergic non-asthma and non-allergic healthy volunteers. The goal is to identify immune “signals” and cell “receptors” involved, which may guide better future treatments.
This study tests if taking one dose of tiotropium can reduce the breathing trouble caused by allergens (like dust mites or pollen) in people with mild to moderate asthma. It aims to see if this medication can protect your lungs during an allergen challenge.
This study tests if a new albuterol inhaler works as well as the standard one for people with mild asthma. You'll breathe in a medicine that measures how your lungs respond, helping show the new inhaler is safe and effective.
This trial tests a new drug called ADO-5030 in people with mild to moderate asthma to see how it affects their airway sensitivity. Participants will have breathing tests using AMP (a substance that can trigger asthma-like symptoms) to measure the drug's effects.
This trial studies how immune cells in the brain (called microglia) may be activated in asthma. You may be able to help researchers test whether a specific “immune pathway” differs in certain asthma patients using brain scans and breathing/allergy testing.
This study checks whether a new albuterol inhaler works the same way as a reference inhaler in adults with stable, mild asthma. It may help you (and others) by confirming that the inhaler delivers the right effect and is safe to use.
Hear when a new Mild Allergic Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.